Lixte Biotechnology Holdings Inc - Will Provide Its Lead Compound, Lb-100, and Roche Will Provide Atezolizumab for Trial
Lixte生物技術控股公司,將提供其主力化合物Lb-100,羅氏將提供Atezolizumab進行試驗。
Lixte Biotechnology Holdings Inc - Will Provide Its Lead Compound, Lb-100, and Roche Will Provide Atezolizumab for Trial
Lixte生物技術控股公司,將提供其主力化合物Lb-100,羅氏將提供Atezolizumab進行試驗。
譯文內容由第三人軟體翻譯。